As pharmas play up their U.S….
As pharmas play up their U.S. investment plans during the [...]
As pharmas play up their U.S. investment plans during the [...]
The director of the National Institutes of Health has attributed the [...]
After HHS abruptly canceled about $500 million in funding for [...]
With the new “Operation Access Now” program, BlinkRx claims drugmakers [...]
Under Robert F. Kennedy Jr., federal officials may withdraw an [...]
The former Texas governor and Trump energy secretary has now [...]
Another Massachusetts biotech has reached the end of the road. [...]
Young inflammatory disease biotech Expedition Therapeutics is paying $17 million [...]
Cold Chain Technologies is eliminating 82 positions at its headquarters [...]
IO Biotech’s cancer vaccine has “narrowly” failed to beat Keytruda [...]